Entries by aaron

Court cannot decide what should be taught in medical education-SC rejects change plea

The Supreme Court recently refused to entertain a Public Interest Litigation (PIL) seeking changes in the medical syllabus. While considering the issue, the Apex Court bench led by Chief Justice of India (CJI) BR Gavai clarified that the court cannot take up the responsibility to decide what should be taught in medical education. “This is […]

Hemodialysis Patients Face Higher Restenosis Risk After DCB Therapy, But Limb Salvage Remains High: POPCORN Registry

Japan: Data from the real-world POPCORN registry has revealed that peripheral artery disease (PAD) patients on hemodialysis experience worse vessel patency after drug-coated balloon (DCB) interventions compared to non-dialysis patients. However, 3-year limb salvage rates remain high, exceeding 90%. The findings, published in JACC: Cardiovascular Interventions by Yasutaka Yamauchi of the Cardiovascular Center, Takatsu General […]

Potassium and Zinc Linked to Lower Depression Risk in New Study

Around 5% of adults have depression world wide. The study found that higher mineral intake is linked to lower depression risk in Korean and American adults. Further research suggests that minerals like potassium and zinc may help reduce the risk of developing depression alongside healthy lifestyle habits. The study was published in the journal of […]

Shunting Benefits in Idiopathic Normal-Pressure Hydrocephalus: NEJM

A new clinical trial published in the New England Journal of Medicine found that among patients with idiopathic normal-pressure hydrocephalus who responded to temporary cerebrospinal fluid (CSF) drainage, shunting significantly improved gait velocity and gait/balance measures at 3 months, but showed no benefit for cognition or incontinence. The study investigated the effects of shunting among patients […]

Epinephrine Nasal Spray Matches Injection Effectiveness for Anaphylaxis: Study

It has been found in real-world data from over 500 patients that a single dose of ARS Pharmaceuticals’ epinephrine nasal spray (neffy) achieved an 89% success rate, comparable to injection outcomes. This large-scale analysis supports neffy as a needle-free alternative for treating anaphylaxis. These findings represent the first large-scale analysis of treatment outcomes with neffy […]

Why breast cancer therapy tamoxifen may lead to higher risk of uterine cancer?

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated in the future Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- to 7-fold increased risk of developing uterine cancer within 2-5 years […]